Is Immune globulin infusion (human) in shortage right now?

No. FDA does not currently list Immune globulin infusion (human) in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Immune globulin infusion (human)?

1 company has marketed Immune globulin infusion (human) in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

Market view

immune globulin infusion (human) · Injection, Solution

8 marketed package NDCs · 1 active manufacturer

Most dispensed: HUMAN IMMUNOGLOBULIN G 100 mg/mL · Injection, Solution · #1 bottle, glass/carton / 200 ml in 1 bottle, glass · HUMAN IMMUNOGLOBULIN G 100 mg/mL · Injection, Solution · #1 bottle, glass/carton / 50 ml in 1 bottle, glass

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $10.53 per mL over the past year.

Price range and competition

RSS: changes for this drug

Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.

Latest · Jul 2025 — typical price $10.53 · middle half $10.34–$10.71 · full range $10.16–$10.90 · 2 products · 1 companies

middle half of companies’ pricestypical (median) pricecompanies actively selling (bottom lane)Priced per mLⓘSource: CMS NADAC

ⓘ How this was built

Data sources

CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
CMS Federal Upper Limit files (weighted AMP)
FDA NDC Directory (openFDA) — maker roster

Method

Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Same drug class

Other molecules FDA puts in Human Immunoglobulin G, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Immune globulin infusion (human) in shortage right now?: No. FDA does not currently list Immune globulin infusion (human) in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Immune globulin infusion (human)?: 1 company has marketed Immune globulin infusion (human) in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.